Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-05-28

FDA Approved: BUSPIRONE HYDROCHLORIDE — Supplemental Application (Oxford Pharmaceuticals, LLC)

View source ↗

Summary

FDA approved a supplemental application for buspirone hydrochloride from Oxford Pharmaceuticals, LLC under the Abbreviated New Drug Application (ANDA) process.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Buspirone hydrochloride (buspirone hydrochloride)

Snippet

SUPPL AP for BUSPIRONE HYDROCHLORIDE (BUSPIRONE HYDROCHLORIDE)